List of SBIR/STTR awards granted to Progenics Pharmaceuticals
Progenics PharmaceuticalsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA091746-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals from the U.S. Department of Health & Human Services. | SBIR | 2R44AI048278-03 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $366,535.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA095928-01 | Phase I | 366,535 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $2,640,409.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI048278-03 | Phase II | 2,640,409 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $3,036,480.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI046871-03 | Phase II | 3,036,480 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals from the U.S. Department of Health & Human Services. | SBIR | 2R44AI046871-03 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $550,179.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA107653-01 | Phase I | 550,179 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $3,029,040.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI051134-03 | Phase II | 3,029,040 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $2,707,682.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM063360-03 | Phase II | 2,707,682 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $614,996.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA121640-01 | Phase I | 614,996 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $196,950.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA092927-01A1 | Phase I | 196,950 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $594,489.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI051134-01A1 | Phase I | 594,489 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $600,638.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI051124-01 | Phase I | 600,638 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $3,830,890.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA096075-03 | Phase II | 3,830,890 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $520,839.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA099466-01 | Phase I | 520,839 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $351,433.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI072780-01 | Phase I | 351,433 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $620,713.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI069675-01 | Phase I | 620,713 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $291,281.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI073223-01 | Phase I | 291,281 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $617,186.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI058820-01 | Phase I | 617,186 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $591,376.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI062473-01 | Phase I | 591,376 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $428,780.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA095928-03A2 | Phase II | 428,780 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $3,635,260.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA091746-02 | Phase II | 3,635,260 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals from the U.S. Department of Health & Human Services. | SBIR | 2R44GM063360-03 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Progenics Pharmaceuticals for $473,537.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA107653-03A2 | Phase II | 473,537 | ||||||||
A SBIR Phase I contract was awarded to Progenics Pharmaceuticals for $525,950.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA099402-01 | Phase I | 525,950 |
